A Glimpse of Abbott Laboratories's Earnings Potential
Portfolio Pulse from Benzinga Insights
Abbott Laboratories (NYSE:ABT) is set to release its quarterly earnings report on October 16, 2024, with analysts expecting an EPS of $1.20. The company's past performance shows a tendency to beat estimates, which has previously led to stock price increases. Analysts have a consensus 'Outperform' rating for Abbott, with a one-year price target of $128.22, suggesting a potential upside. Abbott's revenue growth is 4.0%, and it has a strong net margin of 12.55%.
October 15, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Abbott Laboratories is expected to release its earnings report with an anticipated EPS of $1.20. The company has a history of beating estimates, which has led to stock price increases. Analysts rate the stock as 'Outperform' with a price target of $128.22, indicating a potential upside.
Abbott Laboratories is directly impacted by the upcoming earnings report. Historically, the company has beaten EPS estimates, leading to positive stock price movements. The 'Outperform' rating and price target suggest positive market sentiment, likely driving the stock price up if expectations are met or exceeded.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100